High	0	4	O
density	5	12	O
of	13	15	O
somatostatin	16	28	B-Gene_or_gene_product
receptors	29	38	I-Gene_or_gene_product
in	39	41	O
veins	42	47	B-Multi-tissue_structure
surrounding	48	59	O
human	60	65	B-Organism
cancer	66	72	B-Tissue
tissue	73	79	I-Tissue
:	79	80	O
role	81	85	O
in	86	88	O
tumor	89	94	B-Pathological_formation
-	94	95	O
host	95	99	O
interaction	100	111	O
?	111	112	O

Somatostatin	114	126	B-Gene_or_gene_product
receptors	127	136	I-Gene_or_gene_product
were	137	141	O
detected	142	150	O
in	151	153	O
peritumoral	154	165	O
veins	166	171	B-Multi-tissue_structure
of	172	174	O
various	175	182	O
human	183	188	B-Organism
cancer	189	195	B-Tissue
tissue	196	202	I-Tissue
specimens	203	212	O
.	212	213	O

Vascular	214	222	B-Tissue
and	223	226	O
neoplastic	227	237	B-Tissue
tissue	238	244	I-Tissue
from	245	249	O
14	250	252	O
colonic	253	260	B-Pathological_formation
adenocarcinomas	261	276	I-Pathological_formation
,	276	277	O
13	278	280	O
carcinoids	281	291	B-Pathological_formation
,	291	292	O
6	293	294	O
renal	295	300	B-Pathological_formation
-	300	301	I-Pathological_formation
cell	301	305	I-Pathological_formation
carcinomas	306	316	I-Pathological_formation
and	317	320	O
7	321	322	O
malignant	323	332	B-Pathological_formation
lymphomas	333	342	I-Pathological_formation
were	343	347	O
analyzed	348	356	O
for	357	360	O
somatostatin	361	373	B-Gene_or_gene_product
receptors	374	383	I-Gene_or_gene_product
by	384	386	O
use	387	390	O
of	391	393	O
quantitative	394	406	O
receptor	407	415	O
autoradiography	416	431	O
.	431	432	O

In	433	435	O
colonic	436	443	B-Pathological_formation
carcinoma	444	453	I-Pathological_formation
specimens	454	463	O
,	463	464	O
the	465	468	O
peritumoral	469	480	O
vessels	481	488	B-Multi-tissue_structure
expressed	489	498	O
a	499	500	O
high	501	505	O
density	506	513	O
of	514	516	O
somatostatin	517	529	B-Gene_or_gene_product
receptors	530	539	I-Gene_or_gene_product
,	539	540	O
whereas	541	548	O
the	549	552	O
neoplastic	553	563	B-Tissue
tissue	564	570	I-Tissue
itself	571	577	O
was	578	581	O
receptor	582	590	O
-	590	591	O
negative	591	599	O
in	600	602	O
many	603	607	O
cases	608	613	O
.	613	614	O

In	615	617	O
contrast	618	626	O
,	626	627	O
the	628	631	O
incidence	632	641	O
and	642	645	O
density	646	653	O
of	654	656	O
somatostatin	657	669	B-Gene_or_gene_product
receptors	670	679	I-Gene_or_gene_product
in	680	682	O
peritumoral	683	694	O
vessels	695	702	B-Multi-tissue_structure
was	703	706	O
low	707	710	O
in	711	713	O
well	714	718	O
-	718	719	O
differentiated	719	733	O
gastrointestinal	734	750	B-Pathological_formation
and	751	754	O
bronchial	755	764	B-Pathological_formation
carcinoids	765	775	I-Pathological_formation
,	775	776	O
in	777	779	O
contrast	780	788	O
to	789	791	O
the	792	795	O
high	796	800	O
density	801	808	O
of	809	811	O
such	812	816	O
receptors	817	826	O
in	827	829	O
the	830	833	O
carcinoid	834	843	B-Tissue
tumor	844	849	I-Tissue
tissue	850	856	I-Tissue
.	856	857	O

Autochthonous	858	871	O
vessels	872	879	B-Multi-tissue_structure
surrounding	880	891	O
other	892	897	O
tumors	898	904	B-Pathological_formation
such	905	909	O
as	910	912	O
renal	913	918	B-Pathological_formation
-	918	919	I-Pathological_formation
cell	919	923	I-Pathological_formation
carcinomas	924	934	I-Pathological_formation
or	935	937	O
malignant	938	947	B-Pathological_formation
lymphomas	948	957	I-Pathological_formation
also	958	962	O
frequently	963	973	O
expressed	974	983	O
somatostatin	984	996	B-Gene_or_gene_product
receptors	997	1006	I-Gene_or_gene_product
.	1006	1007	O

In	1008	1010	O
all	1011	1014	O
cases	1015	1020	O
,	1020	1021	O
the	1022	1025	O
somatostatin	1026	1038	B-Gene_or_gene_product
receptors	1039	1048	I-Gene_or_gene_product
were	1049	1053	O
localized	1054	1063	O
in	1064	1066	O
veins	1067	1072	B-Multi-tissue_structure
,	1072	1073	O
particularly	1074	1086	O
in	1087	1089	O
the	1090	1093	O
smooth	1094	1100	B-Cell
-	1100	1101	I-Cell
muscle	1101	1107	I-Cell
cell	1108	1112	I-Cell
layer	1113	1118	O
.	1118	1119	O

They	1120	1124	O
exhibited	1125	1134	O
specific	1135	1143	O
and	1144	1147	O
high	1148	1152	O
-	1152	1153	O
affinity	1153	1161	O
binding	1162	1169	O
of	1170	1172	O
somatostatin	1173	1185	B-Gene_or_gene_product
-	1185	1186	I-Gene_or_gene_product
14	1186	1188	I-Gene_or_gene_product
,	1188	1189	O
somatostatin	1190	1202	B-Gene_or_gene_product
-	1202	1203	I-Gene_or_gene_product
28	1203	1205	I-Gene_or_gene_product
and	1206	1209	O
octreotide	1210	1220	B-Drug_or_compound
,	1220	1221	O
suggesting	1222	1232	O
a	1233	1234	O
preferential	1235	1247	O
expression	1248	1258	O
of	1259	1261	O
the	1262	1265	O
SSTR2	1266	1271	B-Gene_or_gene_product
receptor	1272	1280	I-Gene_or_gene_product
subtype	1281	1288	O
.	1288	1289	O

Since	1290	1295	O
the	1296	1299	O
vessels	1300	1307	B-Multi-tissue_structure
of	1308	1310	O
normal	1311	1317	O
non	1318	1321	O
-	1321	1322	O
neoplastic	1322	1332	O
human	1333	1338	B-Organism
tissues	1339	1346	B-Tissue
,	1346	1347	O
e	1348	1349	O
.	1349	1350	O
g	1350	1351	O
.	1351	1352	O
of	1353	1355	O
intestine	1356	1365	B-Organ
or	1366	1368	O
lymphatic	1369	1378	B-Organ
organs	1379	1385	I-Organ
,	1385	1386	O
have	1387	1391	O
few	1392	1395	O
somatostatin	1396	1408	B-Gene_or_gene_product
receptors	1409	1418	I-Gene_or_gene_product
,	1418	1419	O
the	1420	1423	O
increased	1424	1433	O
somatostatin	1434	1446	B-Gene_or_gene_product
receptor	1447	1455	I-Gene_or_gene_product
expression	1456	1466	O
in	1467	1469	O
peritumoral	1470	1481	O
vessels	1482	1489	B-Multi-tissue_structure
observed	1490	1498	O
in	1499	1501	O
this	1502	1506	O
study	1507	1512	O
may	1513	1516	O
be	1517	1519	O
linked	1520	1526	O
to	1527	1529	O
the	1530	1533	O
neoplastic	1534	1544	O
process	1545	1552	O
itself	1553	1559	O
.	1559	1560	O

The	1561	1564	O
results	1565	1572	O
suggest	1573	1580	O
that	1581	1585	O
somatostatin	1586	1598	B-Gene_or_gene_product
and	1599	1602	O
somatostatin	1603	1615	B-Gene_or_gene_product
receptors	1616	1625	I-Gene_or_gene_product
may	1626	1629	O
play	1630	1634	O
a	1635	1636	O
regulatory	1637	1647	O
role	1648	1652	O
for	1653	1656	O
hemodynamic	1657	1668	O
tumor	1669	1674	B-Pathological_formation
-	1674	1675	O
host	1675	1679	O
interactions	1680	1692	O
,	1692	1693	O
possibly	1694	1702	O
involving	1703	1712	O
tumor	1713	1718	B-Tissue
stroma	1719	1725	I-Tissue
generation	1726	1736	O
,	1736	1737	O
tumor	1738	1743	B-Pathological_formation
environment	1744	1755	O
,	1755	1756	O
angiogenesis	1757	1769	O
and	1770	1773	O
,	1773	1774	O
particularly	1775	1787	O
,	1787	1788	O
vascular	1789	1797	O
drainage	1798	1806	O
of	1807	1809	O
poorly	1810	1816	O
differentiated	1817	1831	O
neoplasms	1832	1841	B-Pathological_formation
.	1841	1842	O

